EuCARE on schools
Our study EuCARE on Italian schools will soon be presented
The variant of interest BA.2.75.2
The new variant BA.2.75.2 is now available and will be added soon to the EuCARE Library of Variants.
The variant of interest BA.2.75.2 Read More »
New paper published on the “Rapid selection of Sotrovimab escape variants in SARS-CoV-2 omicron infected immunocompromised patients”
To read more go to publications or access through the link https://doi.org/10.1093/cid/ciac802
The EuCARE partners were present in the European Researchers’ night 2022 held in Lisbon and Frascati, Rome
The EuCARE partners from the IHMT-NOVA, Lisbon and from the Università degli Studi di Roma Tor Vergata (UNITOV), Italy, were present in the European Researchers’ night 2022 in the 30th of September and 1st of October.
EuCARE annual meeting Lisbon, 15-16th September 2022
The EuCARE anual meeting was held in Lisbon at the Institute of Hygiene and Tropical Medicine on 15th and 16th of September 2022. In this meeting, the overall progress of the project was presented and discussed by all participants.
EuCARE annual meeting Lisbon, 15-16th September 2022 Read More »
Collaboration with INVALSI set up for the study learning loss in Italy
EuCARE has set up a collaboration with the Italian National Institute for the Evaluation of the Education and Training System, INVALSI
Collaboration with INVALSI set up for the study learning loss in Italy Read More »
New paper published on the Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19
To read more go to publications or access through the link https://doi.org/10.3390/vaccines10040550
New paper published on the The Impact of Sport Activity Shut down during the COVID-19 Pandemic by the partner Sara Gandini
A paper on the The Impact of Sport Activity Shut down during the COVID-19 Pandemic on Children, Adolescents, and Young Adults.
To read more go to publications or access through the link https://www.mdpi.com/1660-4601/19/13/7908#cite
New paper published on the Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against SARS-CoV-2 variants by the partners of UniSiena
SARS-CoV-2 variants may escape monoclonal antibodies (mAbs) and antiviral drugs. This paper investigates differences in activity of mABs and antiviral drugs against newly emerging SARS-CoV-2 variants. To read more go to publications or access through the link https://www.mdpi.com/1999-4915/14/7/1374
A new paper published on the comparison of the three most recent pandemics: Influenza, HIV and SARS-CoV-2 by the partners of UNL-IHMT
This is a review paper where it is highlighted the main determinants of the emergence, epidemic response and available countermeasures of these three pandemics, and argued that such knowledge is paramount to prepare for the next pandemic. To read more about it go to publications or access through the link https://www.frontiersin.org/articles/10.3389/fmicb.2022.889643/full